Navigation Links
HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
Date:2/26/2008

NEW YORK and DALLAS, Feb. 26 /PRNewswire/ -- HealthpointCapital, LLC. ("HealthpointCapital") announced today that it has appointed Dr. Stephen H. Hochschuler as Clinical Advisor to the Firm. HealthpointCapital is a values- driven, research-based private equity firm exclusively focused on orthopedic and dental device companies. Dr. Hochschuler is the co-founder of the Texas Back Institute, Chairman of Texas Back Institute Holdings and Chairman of the Board, a founding member and former President of the Spine Arthroplasty Society and a board certified orthopedic surgeon.

"We are very pleased that Dr. Hochschuler is joining us as Clinical Advisor," stated Mortimer Berkowitz III, President of HealthpointCapital. "Investing in companies that improve patient care is central to HealthpointCapital investment thesis which means we are continually deepening our scientific knowledge and relationships in order to build companies that offer the most innovative products and best clinical outcomes. Dr. Hochschuler's unparalleled understanding of medical science and advanced technologies will allow us to better deliver to the marketplace and create value for our investors."

Dr. Stephen H. Hochschuler stated, "I am pleased to be working more closely with HealthpointCapital. The firm's research and investment teams have demonstrated their commitment to developing strategies and organizations that are responsive surgeons' needs through innovative product development. I am confident that this partnership will lead to important advancements in the orthopedic device industry."

For More Information:

Lauren Uzdienski

HealthpointCapital, LLC

212.935.7780

http://www.healthpointcapital.com

About HealthpointCapital

HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the orthopedic and dental device businesses. HealthpointCapital has $650 million of institutional capital under management. The firm believes it is the only of its kind to focus exclusively on late stage opportunities in the $30 billion worldwide orthopedic and dental device industry. The firm's professionals have a cumulative 85 years of experience in healthcare investing and technology. The firm also publishes extensively on musculoskeletal technologies and industry activities on its dedicated research site at http://www.healthpointcapital.com


'/>"/>
SOURCE HealthpointCapital, LLC.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath Appoints New Chief Financial Officer
2. Ceremed Appoints Vice President for Sales and Business Development
3. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
4. Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
5. AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors
6. Natural Alternatives International, Inc. Appoints New Chief Financial Officer
7. Deerfield Spa Appoints New Fitness Director
8. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
9. P\S\L Group appoints Paul Barnes as Group President P\S\L Research
10. AtriCure Appoints Mark A. Collar to its Board of Directors
11. Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: